- Home
- CEPU vs LGND Comparison
CEPU vs LGND Comparison
Compare CEPU & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- LGND
- Stock Information
- Founded
- CEPU 1989
- LGND 1987
- Country
- CEPU Argentina
- LGND United States
- Employees
- CEPU N/A
- LGND N/A
- Industry
- CEPU Electric Utilities: Central
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- LGND Health Care
- Exchange
- CEPU Nasdaq
- LGND Nasdaq
- Market Cap
- CEPU 2.1B
- LGND 2.3B
- IPO Year
- CEPU 2018
- LGND 1992
- Fundamental
- Price
- CEPU $13.67
- LGND $114.64
- Analyst Decision
- CEPU Hold
- LGND Strong Buy
- Analyst Count
- CEPU 1
- LGND 6
- Target Price
- CEPU $12.00
- LGND $145.00
- AVG Volume (30 Days)
- CEPU 377.6K
- LGND 134.9K
- Earning Date
- CEPU 11-08-2024
- LGND 11-07-2024
- Dividend Yield
- CEPU 1.41%
- LGND N/A
- EPS Growth
- CEPU 219.02
- LGND 160.46
- EPS
- CEPU 0.13
- LGND 2.47
- Revenue
- CEPU $375,582,169.00
- LGND $152,422,000.00
- Revenue This Year
- CEPU $101.46
- LGND $26.86
- Revenue Next Year
- CEPU $61.85
- LGND $13.16
- P/E Ratio
- CEPU $12.06
- LGND $46.38
- Revenue Growth
- CEPU N/A
- LGND N/A
- 52 Week Low
- CEPU $7.07
- LGND $67.53
- 52 Week High
- CEPU $16.34
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- CEPU 48.48
- LGND 46.50
- Support Level
- CEPU $14.73
- LGND $113.39
- Resistance Level
- CEPU $16.34
- LGND $124.03
- Average True Range (ATR)
- CEPU 0.79
- LGND 5.75
- MACD
- CEPU -0.20
- LGND -1.02
- Stochastic Oscillator
- CEPU 17.44
- LGND 21.59
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.